(Q44939855)

English

Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

tetanus vaccine

1 reference

based on heuristic

inferred from title

pertussis vaccine

1 reference

based on heuristic

inferred from title

author name string

Wayde M Weston

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Leonard R Friedland

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Xiangfeng Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Barbara Howe

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

31 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1721-1728

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

A "new age" in pertussis prevention new opportunities through adult vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

A pertussis outbreak associated with social isolation among elderly nuns in a convent.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Infant pertussis: who was the source?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Transmission of Bordetella pertussis to young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Efficacy of acellular pertussis vaccine in early childhood after household exposure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

An epidemic of pertussis among elderly people in a religious institution in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.055

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.12.055

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

release_seemwinb5jhn3ocw5axx3bd3ou

1 reference

https://api.fatcat.wiki/v0/release/seemwinb5jhn3ocw5axx3bd3ou

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44939855&oldid=2058810976"